RCEL - AVITA Medical GAAP EPS of -$0.34 beats by $0.10 revenue of $13.5M beats by $0.21M
2023-11-09 16:06:26 ET
- AVITA Medical press release ( NASDAQ: RCEL ): Q3 GAAP EPS of -$0.34 beats by $0.10 .
- Revenue of $13.5M (+48.5% Y/Y) beats by $0.21M .
- Commercial revenue for the fourth quarter 2023 is expected to be in the range of $15.3 to $16.3 million.
- Commercial revenue for the full year 2023 is expected to be in the range of $51 to $53 million.
For further details see:
AVITA Medical GAAP EPS of -$0.34 beats by $0.10, revenue of $13.5M beats by $0.21M